SUBRAMANIAN, BOOPATHI
BIOLOGÍA · Nivel 1
Desde 2026 es Assistant Professor en SRM Institute of Science and Technology
I was born on July 30, 1986, in the small town of Mallasamudram, Tamil Nadu, India, into a traditional handloom-weaver...
I was born on July 30, 1986, in the small town of Mallasamudram, Tamil Nadu, India, into a traditional handloom-weaver family. Growing up in this environment instilled in me the values of perseverance, discipline, and craftsmanship, which later shaped my scientific mindset. Guided by curiosity and determination, I pursued higher studies in physics, earning my B.Sc., M.Sc., M.Phil., and Ph.D. I gradually built a research career dedicated to unraveling the molecular mechanisms of Alzheimer’s disease. Since 2010, my research has focused on the molecular basis of Alzheimer’s disease, particularly the oligomerization of amyloid-β, protein-membrane interactions, and their roles in neurotoxicity. I have published approximately 20 papers in leading international journals and have over eight years of postdoctoral research experience across five countries: South Korea, Poland (as a Marie Curie fellow), Chile, Mexico (at UNAM, a top 100 world-ranked university), and India (at IIT Madras, a top 200 world-ranked university). A major highlight of my work is the rational design of M30, a novel small-molecule inhibitor that blocks amyloid toxicity and restores memory in Alzheimer’s disease models—an exciting candidate for future therapeutics. In addition to my research, I actively engage in science communication, writing in Tamil to bring awareness of neuroscience and brain health to the public.
Índice de visibilidad digital v1.0 · Mide qué tan completo está el perfil, no la calidad académica. Escala: 0–39 incompleto · 40–79 intermedio · 80–100 completo. ¿Cómo se calcula? · ¿Te falta un dato? Avísanos
| Nombre | BOOPATHI SUBRAMANIAN |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | BIOLOGÍA |
| Disciplina | BIOFÍSICA |
| Especialidad | ALZHEIMER |
| CVU | 1133880 |
| Institución |
SIN INSTITUCIÓN
|
|---|---|
| Dependencia | NO APLICA |
| Entidad | NO APLICA |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2027 |
Evolución en el SNII
- Nivel I: 2023–2026
Últimas publicaciones Scopus
- 2026
- Herpes Simplex Virus Glycoprotein D Associated with Aβ1–42Tetramers Mediates Neurotoxicity by Perturbing Neuronal Membrane Integrity: A Molecular Dynamics Simulation ACS Chemical Neuroscience · Vol. 17 Article
- 2024
- A Small Molecule Impedes the Aβ1-42 Tetramer Neurotoxicity by Preserving Membrane Integrity: Microsecond Multiscale Simulations ACS Chemical Neuroscience · Vol. 15 Article
- 2022
- Calcium inhibits penetration of Alzheimer's Aβ1–42 monomers into the membrane Proteins Structure Function and Bioinformatics · Vol. 90 Article
- 2021
- The stimulatory effects of intracellular α-synuclein on synaptic transmission are attenuated by 2-octahydroisoquinolin-2(1h)-ylethanamine International Journal of Molecular Sciences · Vol. 22 Article
- An overview of several inhibitors for alzheimer’s disease: Characterization and failure International Journal of Molecular Sciences · Vol. 22 Review


